Key Performance Indicators
Chemiesynth(Vapi is currently trading at Rs 66.84 on the BSE under ticker CHEMIESYNTH, carrying a market capitalisation of Rs 20.52 crore. A price-to-earnings ratio is not reported for the current period, reflecting the company's current earnings profile. The six-month price return is +77.62%. The most recently reported quarterly net profit Rs 0.60 crore, representing a year-on-year change of 215.79%. Quarterly sales stand at Rs 5.50 crore, with a year-on-year change of -17.66%. The return on capital employed (ROCE) is -0.23%. The all-time high price is Rs 66.84 — the stock is currently trading at or near its all-time high.
Highlights
Chemiesynth(Vapi has delivered a six-month price return of 77.62%, placing it among the notable performers on the BSE over the measured period. The current price of Rs 66.84 coincides with the all-time high — the stock is trading at its strongest price point in its listed history, with no established overhead resistance. The market capitalisation of Rs 20.52 crore at this price level reflects the cumulative re-rating the market has applied to the company's equity.
A price-to-earnings ratio is not currently calculable, as the company's most recent reported quarter shows a net loss rather than a profit — a common feature of early-stage or transitional businesses that have been re-rated on expected future earnings rather than current profitability. India's industrial and manufacturing growth, supported by PLI schemes and infrastructure investment, provides structural demand tailwinds.
Business Overview
Chemiesynth (Vapi) is a specialty chemicals company based in Vapi, Gujarat — one of India's most significant industrial chemical manufacturing clusters, located in the Golden Corridor of south Gujarat. Vapi's industrial infrastructure — chemical zone, port access, established supply chains, and technical workforce — provides an operational advantage for chemical manufacturers. The company produces specialty chemicals for industrial, agrochemical, or pharmaceutical applications.
The quarterly profit of Rs 0.60 crore with an exceptional growth rate of 215.79% indicates the business has turned the corner on profitability — moving from losses to positive earnings with strong growth momentum. The current price at the all-time high of Rs 66.84 reflects the market's positive assessment of this trajectory. Quarterly sales of Rs 5.50 crore with a slight decline of -17.66% suggest revenue is stabilising while margins improve. The ROCE of -0.23% is barely negative, suggesting capital efficiency is approaching breakeven at the current stage.
Financial Analysis
The financial profile of Chemiesynth(Vapi requires careful contextualisation. The six-month return of 77.62% has generated a nano-cap valuation of Rs 20.52 crore which must be assessed against the current operational scale: quarterly revenue of Rs 5.50 crore and quarterly net profit of Rs 0.60 crore. Without a positive P/E, the stock is valued on anticipated future earnings — a framework that requires visibility on the path to profitability and the timeline for achieving it.
The return on capital employed of -0.23% is negative, indicating the business is currently consuming capital rather than generating returns on it — a position that requires monitoring to assess whether the path to positive ROCE is visible through improving revenue and margin trends. The quarterly revenue decline of -17.66% year-on-year is a near-term concern that investors should investigate through the company's quarterly results commentary.
At a market capitalisation of Rs 20.52 crore, Chemiesynth(Vapi is a nano-scale listed entity. The practical implications of investing at this scale include very limited daily liquidity, potentially very wide bid-ask spreads, and extreme price sensitivity to individual transactions. These structural market microstructure factors amplify both the percentage gains during re-rating phases and the percentage losses during correction phases.
Investor Highlights
The investment case for Chemiesynth(Vapi at the current price is determined by the gap between the current market capitalisation of Rs 20.52 crore and the company's intrinsic business value — a calculation that depends on assumptions about future revenue growth, margin improvement, and competitive positioning. The six-month return of 77.62% identifies this as a stock that the market has chosen to dramatically revalue upward, with the analytical question being whether the current valuation level is justified by the fundamental business trajectory.
With the stock at its all-time high of Rs 66.84, there is no historical price resistance above the current level — the near-term direction is determined by fresh fundamental news and market sentiment rather than by established supply-demand dynamics from prior sellers at higher prices.
The positive quarterly profitability of Rs 0.60 crore provides a fundamental anchor that distinguishes Chemiesynth(Vapi from the pre-revenue or loss-making entities in this collection. A profitable business — even at thin absolute levels — provides the basis for P/E-based valuation, dividend capacity assessment, and earnings trend analysis that loss-making businesses cannot.
Frequently Asked Questions
Q: What does Chemiesynth(Vapi do and what sector does it operate in?
A: Chemiesynth(Vapi operates in the industrials sector, listed on the BSE under the ticker CHEMIESYNTH. The company's specific products, services, revenue model, and customer base are documented in its annual report and exchange filings available through the BSE corporate filing portal at bseindia.com.
Q: What does the six-month return of 77.62% reflect for Chemiesynth(Vapi?
A: The six-month return of 77.62% reflects significant positive market re-rating of the company's equity from its price six months prior. This re-rating may be driven by company-specific developments — new contracts, business expansion, or improved financial performance — or by broader sector-level positive sentiment. Investors should verify the specific triggers through the company's BSE exchange disclosures and quarterly results.
Q: How should investors value Chemiesynth(Vapi without a positive P/E ratio?
A: When a company reports a net loss, conventional P/E-based valuation is not directly applicable. Investors typically use price-to-sales, price-to-book, or discounted cash flow analysis — all of which require assumptions about when profitability will be achieved and at what margin level. The company's management commentary on the profitability path is a key input for this assessment.
Q: What is Chemiesynth(Vapi's current market capitalisation and all-time high?
A: Chemiesynth(Vapi has a market capitalisation of Rs 20.52 crore at the current price of Rs 66.84. The all-time high is Rs 66.84 — the same as the current price, confirming the stock is at its historical high with no precedent for prices at this level.
Q: Where can investors find Chemiesynth(Vapi's official financial data and corporate disclosures?
A: All of Chemiesynth(Vapi's financial disclosures — quarterly results, annual reports, shareholding patterns, board announcements, and corporate actions — are filed with the BSE and are freely accessible at bseindia.com through the company's filing page. SEBI's listing obligations mandate timely disclosure of all material developments. These filings are the primary source of verified financial and operational information for investment assessment.